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Abstract
In medicine, both ethical and monetary costs of incorrect predictions can be signifi-
cant, and the complexity of the problems often necessitates increasingly complex
models. Recent work has shown that changing just the random seed is enough for
otherwise well-tuned deep neural networks to vary in their individual predicted
probabilities. In light of this, we investigate the role of model uncertainty methods
in the medical domain. Using recurrent neural network (RNN) ensembles and
various Bayesian RNNs, we show that population-level metrics, such as AUC-PR,
AUC-ROC, log-likelihood, and calibration error, do not capture model uncertainty.
Meanwhile, the presence of significant variability in patient-specific predictions
and optimal decisions motivates the need for capturing model uncertainty. Under-
standing the uncertainty for individual patients is an area with clear clinical impact,
such as determining when a model decision is likely to be brittle. We further show
that RNNs with only Bayesian embeddings can be a more efficient way to capture
model uncertainty compared to ensembles, and we analyze how model uncertainty
is impacted across individual input features and patient subgroups.
1 Introduction
Machine learning has found great and increasing levels of success in the last several years on many
well-known benchmark datasets. This has led to a mounting interest in non-traditional problems
and domains, each of which bring their own requirements. In medicine specifically, individualized
predictions are of great importance to the field [1], and there can be severe costs for incorrect
predictions and decisions due to the risk to human life and the associated ethical concerns [2].
Existing state-of-the-art approaches using deep neural networks in medicine often make use of either
a single model or an average over a small ensemble of models, focusing on improving the accuracy
of probabilistic predictions [3–6]. These works, while focusing on capturing the data uncertainty,
do not address the model uncertainty that is inherent in fitting deep neural networks. For example,
when predicting patient mortality in an ICU setting, existing approaches might be able to achieve
high AUC-ROC, but will be unable to differentiate between patients for whom the model is certain
about its probabilistic prediction, and those for whom the model is fairly uncertain.
In this paper, we examine the use of model uncertainty specifically in the context of predictive
medicine. Model uncertainty has made many methodological advances in recent years—including
reparameterization-based variational Bayesian neural networks [7–9], Monte Carlo dropout [10], en-
sembles [11], and function priors [12–14]. In order to directly impact clinical care, model uncertainty
methods raise several natural questions:
• How do the realized functions in any of the approaches, such as individual models in the
ensemble approach, compare in terms of metric performance such as AUC-PR, AUC-ROC,
or log-likelihood?
∗Work done as a Google AI Resident.
ar
X
iv
:1
90
6.
03
84
2v
1 
 [c
s.L
G]
  1
0 J
un
 20
19
• If and how does model uncertainty assist in calibrating predictions?
• What is the effect of uncertainty on predictions across patient subgroups, such as by race,
gender, age, or length of stay?
• Which feature values are responsible for the highest model uncertainty?
• How does model uncertainty affect optimal decisions made under a given clinically-relevant
cost function?
Contributions Using sequence models on the MIMIC-III clinical dataset [15], we make several
important findings. For the ensembling approach of quantifying model uncertainty, we find that
the models within the ensemble are nearly identical in terms of dataset-level metric performance,
despite each model yielding different patient-specific predictions. In addition to the strong metric
performance, the models in the ensemble also appear to be well-calibrated. It is therefore likely
that any one of these models could be selected in practice if we were only using one model for our
clinical problem. Furthermore, we see that predictive uncertainty due to model uncertainty extends
into the space of optimal decisions. That is, models with nearly equivalent performance can disagree
significantly on the final decision.
Overall, we show that model uncertainty is not captured by dataset-level (i.e., population-level)
metrics, such as AUC-PR, AUC-ROC, log-likelihood, and calibration error. Rather, the significant
variability in sample-specific (i.e., patient-specific) predictions and decisions motivates the importance
of model uncertainty; this is an area with clear clinical impact. Additionally, we show that models
with Bayesian embeddings can be a more efficient way to capture model uncertainty compared to
ensembles, and we analyze how model uncertainty is impacted across individual input features and
patient subgroups.
2 Background
Data uncertainty Data uncertainty can be viewed as uncertainty regarding a given outcome due to
incomplete information, and is also known as “output uncertainty” or “risk” [16]. For binary tasks,
this equates to a single probability value. More specifically, this can be described as
λ = f(x,w)
y ∼ Bernoulli(λ), (1)
where the model f , as a function of the inputs x and parameters w, outputs the parameter λ for a
Bernoulli distribution representing the conditional distribution p(y|x,w) for the outcome y.
Model uncertainty Model uncertainty can be viewed as uncertainty in the correct values of the
parameters for the predictive outcome distribution due to not knowing the true function. For binary
tasks, this equates to a distribution of plausible probability values for a Bernoulli distribution,
corresponding to a set of plausible functions. More specifically, this can be described as
λ ∼ p(λ|x,w)
y ∼ Bernoulli(λ), (2)
where there is a distribution over the Bernoulli parameter λ for a given example that represents
uncertainty in the true outcome distribution due to uncertainty in function space. For the remainder
of the paper, we will use the phrase predictive uncertainty distribution to refer to this distribution
over the parameter of the outcome distribution.
Deep Ensembles Deep ensembles [11] is a method for quantifying model uncertainty. In this
approach, an ensemble of deterministic2 neural networks (NNs) is trained by varying only the
random seed of an otherwise well-tuned model. Given this ensemble, predictions can be made with
each model m for a given example i, where (for a binary task) each prediction is the probability
parameter λ(i)m for the Bernoulli distribution over the outcome. The set of probabilistic predictions
{λ(i)1 , λ(i)2 , . . . , λ(i)M } for the same example can then be viewed as the distribution p(λ|x,w) over
λ(i), where this distribution represents model uncertainty.
2We use the term “deterministic" to refer to the usual setup in which we optimize the parameter values of our
function directly, yielding a trained model with fixed parameter values at test time.
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Figure 1: A histogram of predictions from M
RNN models for the probability of mortality
for a given patient in the ICU. The predictions
form a predictive uncertainty distribution for the
patient, where the disagreement is due to model
uncertainty. This is not captured when using a
single model or an average over an ensemble.
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Figure 2: A plot of the mean versus standard
deviation of the predictive uncertainty distribu-
tions of the deterministic ensemble for positive
and negative patients in the validation set. We
find that the standard deviations are not simple
functions of the mean, and are instead condi-
tioned on each individual patient. For reference,
we note that the variances of the distributions
are generally lower than that of a Bernoulli dis-
tribution’s variance curve.
Bayesian RNNs Bayesian recurrent neural networks (RNNs) [17] are RNNs in which the param-
eters are represented by distributions. This allows us to express model uncertainty as uncertainty
over the true values for the parameters in the model, i.e., “weight uncertainty" [7]. By introducing a
distribution over all, or a subset, of the weights in the model, we can induce different functions, and
thus different outcomes, through realizations of different weight values via draws from the posterior
distributions. This allows us to empirically capture model uncertainty in the predictive uncertainty
distribution p(λ|x,w) by drawing M samples from a trained Bayesian RNN for a given example.
3 Medical Uncertainty
3.1 Mortality Prediction From Medical Records
Similar to Rajkomar et al. [4], we train deep RNNs to predict patient mortality on MIMIC-III [15],
an EHR dataset collected from 46,520 patients admitted to intensive care units (ICUs) at Beth
Israel Deaconess Medical Center, where 9,974 expired during the encounter (i.e., 1:4 ratio between
positive and negative samples). Our model embeds and aggregates a patient’s time-series features (e.g.
medications, lab measures) and global features (e.g. gender, age), feeds them to one or more long
short-term memory (LSTM) layers [18], and follows that with fully-connected hidden and output
affine layers, with a final sigmoid output for binary prediction. See the Appendix for more details.
Existing deep learning approaches in predictive medicine focus on capturing data uncertainty, namely
accurately predicting the risk λ = f(x,w) of a patient’s mortality (i.e., how likely is the patient to
expire?). This work, on the other hand, also focuses on addressing the model uncertainty aspect of
deep learning, namely the distribution λ ∼ p(λ|x,w) over the risk of mortality for a patient (i.e., are
there alternative risk predictions, and if so, how diverse are they?).
3.2 Predictive Uncertainty Distributions
To quantify model uncertainty for our mortality prediction task, we explore the use of deep RNN
ensembles and various Bayesian RNNs. For the deep ensembles approach, we optimize for the ideal
hyperparameter values for our RNN model via black-box Bayesian optimization [19], and then train
M replicas of the best model. Only the random seed differs between the replicas. At prediction
time, we make predictions with all M models for each patient. For the Bayesian RNNs, we take a
variational inference approach by adapting our RNNs to use factorized weight posteriors q(w|θ) =∏
i q(wi|θi),where weight tensors wi in the models are represented by normal distributions with
learnable mean and diagonal covariance parameters represented as θi. Normal distributions with zero
mean and tunable standard deviation are used as weight priors. We train our models by minimizing
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the Kullback-Leibler (KL) divergence
L(θ) = KL[q(w|θ) ‖ p(w|y,X)]
= KL[q(w|θ) ‖ p(w)]− Eq(w|θ) [ln p(y|X,w)] (3)
between the approximate weight posterior and the true, but unknown posterior, which overall equates
to minimizing an expectation over the usual negative log likelihood term plus a KL regularization
term. To easily shift between the deterministic and Bayesian models, we make use of the Bayesian
Layers [20] abstractions.
Figure 1 visualizes the predictive uncertainty distribution for a single patient. We find that there
is a wide variability in predicted Bernoulli probabilities for some patients (with spreads as high as
57.5%), which we will show is often of concern for clinical practice.
3.3 Optimal Decisions Via Sensitivity Requirements
While predicted probabilities of the binary mortality outcome are important, the key desire for clinical
practice is to make a decision. Given a set of potential outcomes yk, a set of conditional probabilities
p(yk|x) for the given outcomes, and the associated costs Lkj of correctly and incorrectly predicting
the correct outcome, an optimal decision can be determined by minimizing the expected decision loss
E[L] =
∑
k
∑
j
∫
Rj
Lkjp(yk|x)p(x) dx, (4)
whereRj is the decision region for assigning example x to class j, and p(x) is the density of x [21].
Unfortunately, designing decision cost functions for clinical applications is difficult, and is a research
problem in itself. That being said, we do have an alternative target that is already clinically relevant:
sensitivity requirements. Often in clinical research, certain sensitivity (i.e., recall) levels must be met
when making binary predictions in order for a model to be clinically relevant. The goal in these cases
is to maximize the precision while still reaching the required recall level. Viewed as a decision cost
function, the cost is infinite if the recall is below the target level, and is otherwise minimized as the
precision is increased, where the optimized parameter is the global probability threshold.
For each of the M models in our ensemble, we can optimize the sensitivity-based decision cost
function and make optimal decisions for all examples. Thus, for each example, there will be a set of
M optimal decisions, forming a distribution. The optimal decision d then becomes a random variable
φ =
1
M
∑
λ∈Λ
1(λj > t)
d ∼ Bernoulli(φ),
(5)
where φ is the percentage of the set Λ = {λ1, λ2, . . . , λM} of M probability values for a given
example that are greater than or equal to the optimized decision threshold t.
4 Experiments
We perform four sets of experiments. First, we examine the relationship of individual model samples
across clinical metrics, calibration, uncertainty distributions, and decision-making. Second, we
examine where uncertainty in the model matters most. Third, we examine patterns in uncertainty
across patient subgroups. Finally, we examine patterns in uncertainty across individual features.
4.1 Deep RNN Ensemble for Mortality Prediction
Clinical Metrics We measure the metric performance of each model in our ensemble on the
mortality task, where our clinically-relevant metrics are the area under the precision-recall curve
(AUC-PR) and area under the receiver operating characteristic curve (AUC-ROC). Table 1 shows the
mean and standard deviation of the metrics for the models in our deterministic ensemble on both the
validation and test sets. For the ensemble, we find that the models are nearly equivalent in terms of
performance, and it is highly likely that any one could have been selected in practice if we were only
using one model for our clinical problem.
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Table 1: Metric performance statistics for the mortality task across M = 200 models in the
deterministic RNN ensemble. The models are nearly identical in terms of dataset-level performance.
METRIC MEAN STANDARD DEVIATION
VAL. AUC-PR 0.4496 0.0025
VAL. AUC-ROC 0.8753 0.0019
TEST AUC-PR 0.3886 0.0059
TEST AUC-ROC 0.8623 0.0031
Table 2: Calibration error mean and standard deviation statistics for the M = 200 models in the
deterministic RNN ensemble (lower values are better). We find that the models are well-calibrated,
thus limiting concerns about over- or under-confident predictions.
CALIBRATION MEASURE MEAN STANDARD DEVIATION
VAL. ECE 0.0176 0.0040
VAL. ACE 0.0210 0.0042
TEST ECE 0.0162 0.0043
TEST ACE 0.0233 0.0057
Calibration A model is said to be perfectly calibrated if, for all examples for which the model
produces the same prediction p for some outcome, the percentage of those examples truly associated
with the outcome is equal to p, across all values of p. If a model is systematically over- or under-
confident, it can be difficult to reliably use its predicted probabilities for decision making. Using the
Expected Calibration Error (ECE) metric [22] as a tractable way to approximate the calibration of a
model given a finite dataset, we measure the calibration of each of the models in our deterministic
ensemble. We also make use of Adaptive Calibration Error (ACE) [23]. Table 2 shows the mean
and standard deviation of the calibration metrics for the models in our deterministic ensemble. The
models are all well-calibrated, indicating that they could each be nearly equally reliable in practice.
Predictive Uncertainty Distributions & Statistics Knowing that the models in our ensemble are
well-calibrated and effectively equivalent in terms of performance, we turn to making predictions for
individual examples. As seen previously in Figure 1, the predictive uncertainty distributions can be
wide for some patients. Figure 2 visualizes the means versus standard deviations of the predictive
uncertainty distributions for the deterministic ensemble on all validation set examples. In contrast
to the variance of a Bernoulli distribution, which is a simple function of the mean, we find that the
standard deviations are patient-specific, and thus cannot be determined a priori.
Optimal Decision Distributions & Statistics In practice, model uncertainty is only important if it
affects the decisions one would make. To test this, we optimize the recall-based decision cost function
with respect to the probability threshold for each model separately to achieve a recall of 70%, and
then make optimal decisions for each example with each of the M models. Figure 3 visualizes how
model uncertainty in probability space is realized in optimal decision space for two patients. We see
that the model uncertainty does indeed extend into the optimal decision space, converting the optimal
decision into a random variable. Furthermore, the decision distribution’s variance can be quite high,
and knowing when this is the case is important in order to avoid the cost of any incorrect decisions.
Additional Clinical Tasks We additionally examined the role of model uncertainty with the de-
terminstic ensemble on the Clinical Classifications Software (CCS) [24] multiclass task, where
ICD-9-CM diagnosis codes are categorized into 285 distinct categories. See the Appendix for details.
4.2 Bayesian RNNs for Mortality Prediction
A natural question in practice is where precisely to be uncertain in the model. To do so, we study
Bayesian RNN under a variety of priors:
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Figure 3: Left two: A set of predictive uncertainty distributions from our deterministic ensemble for
two patients in the validation dataset on the mortality task. Right two: The corresponding optimal
decision distributions. For some patients, such as the one on the left, the ensemble is relatively certain
about the optimal decision, while for other patients, such as the one on the right, there is a large
amount of uncertainty.
Table 3: Metrics for marginalized predictions on the mortality task for an average over M = 200
models in the deterministic RNN ensemble, and M = 200 samples from each of the Bayesian RNN
models. Held-out log-likelihood values are normalized by the number of dataset examples.
MODEL VAL.AUC-PR
VAL.
AUC-ROC
VAL. LOG-
LIKELIHOOD
TEST
AUC-PR
TEST
AUC-ROC
TEST LOG-
LIKELIHOOD
DETERMINISTIC ENSEMBLE 0.4550 0.8774 -0.7113 0.3921 0.8646 -0.7148
BAYESIAN EMBEDDINGS 0.4551 0.8773 -0.7153 0.3965 0.8614 -0.7186
BAYESIAN OUTPUT 0.4358 0.8714 -0.7058 0.3679 0.8570 -0.7087
BAYESIAN HIDDEN+OUTPUT 0.4480 0.8749 -0.7118 0.3885 0.8606 -0.7149
BAYESIAN RNN+HIDDEN+OUTPUT 0.4384 0.8674 -0.7097 0.3844 0.8541 -0.7125
FULLY BAYESIAN 0.4328 0.8691 -0.7100 0.3804 0.8549 -0.7133
• Bayesian Embeddings A Bayesian RNN in which the embedding parameters are stochastic,
and all other parameters are deterministic.
• Bayesian Output A Bayesian RNN in which the output layer parameters are stochastic, and
all other parameters are deterministic.
• Bayesian Hidden+Output A Bayesian RNN in which the hidden and output layer parame-
ters are stochastic, and all other parameters are deterministic.
• Bayesian RNN+Hidden+Output A Bayesian RNN in which the LSTM, hidden, and output
layer parameters are stochastic, and all other parameters are deterministic.
• Fully Bayesian A Bayesian RNN in which all parameters are stochastic.
Table 3 displays the metrics over marginalized predictions for the each of the Bayesian RNN models
and the deterministic RNN ensemble on the mortality task. We find that the Bayesian Embeddings
RNN model outperforms all other Bayesian variants and slightly outperforms the deterministic
ensemble in terms of AUC-PR. Additionally, all of the Bayesian variants are either comparable or
outperform the deterministic ensemble in terms of held-out log-likelihood.
Figure 4 visualizes the predictive distributions of both the Bayesian RNN and the deterministic RNN
ensemble for four individual patients. We find that the Bayesian model is qualitatively able to capture
model uncertainty that is quite similar to that of the deterministic ensemble.
4.3 Patient Subgroup Analysis
We next turn to an exploration of the effects of model uncertainty across patient subgroups. For this
analysis, we use the deterministic RNN ensemble. We split patients into subgroups by demographic
characteristics, namely gender (male vs. female) or age (adult patients divided into quartiles, with
neonates as a separate fifth group). We stratify our performance metrics by subgroup and examine
correlations between these metrics to evaluate whether the ensemble models tend to specialize to one
or more subgroups, at the cost of performance on others. We find some evidence of this phenomenon:
for example, AUC-PR for male patients is negatively correlated with AUC-PR for female patients
(Pearson’s r = −0.442, see Figure 5), and AUC-PR for the oldest quartile of adult patients is
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Figure 4: Predictive uncertainty distributions of both the RNN with Bayesian embeddings and the
deterministic RNN ensemble for individual patients. We find that the Bayesian model is qualitatively
able to capture model uncertainty that is quite similar to that of the ensemble.
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Figure 5: Left: Model performance comparison on male vs. female patients. Each point represents
stratified AUC-PR for a single model. Correlation coefficient r = −0.442. Right: Summary of
uncertainty measures within each age subgroup. On all measures, uncertainty increases monotonically
with age. This corresponds to an increase in mortality rate with age, as positive cases are more
uncertain on average.
somewhat negatively correlated with AUC-PR for other adults or for neonates (Pearson’s r between
−0.18 and −0.37).
We also compare uncertainty metrics across subgroups, including standard deviation and range of
the predictive uncertainty distributions and variance of the optimal decision distributions for patients
in each subgroup. We find that all metrics are correlated with subgroup label prevalence: both
uncertainty and mortality rate increase monotonically across age groups (Figure 5), and both are
slightly higher in women than in men. These findings imply that random model variation during
training may actually cause unintentional harm to certain patient populations, which may not be
reflected in aggregate performance.
4.4 Embedding Uncertainty Analysis
Another motivation for model uncertainty lies in understanding which feature values are most
responsible for the variance of the predictive uncertainty distribution. Our RNN with Bayesian
embeddings model is particularly well suited for this task in that the uncertainty in embedding space
directly corresponds to the predictive uncertainty distribution and represents uncertainty associated
with the discrete feature values. Understanding model uncertainty associated with features can allow
us to recognize particularly difficult examples and understand which feature values are leading to
the difficulties. Additionally, it provides a means of determining the types of examples that could be
beneficial to add to the training dataset for future updates to the model.
For this analysis, we focus on the free-text clinical notes found in the EHR. For each word in the notes
vocabulary, we have an associated embeddings distribution formulated as a multivariate Normal. We
rank each word by its level of model uncertainty (measured by its embedding distribution’s entropy).
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Figure 6: Correlation between the entropy of the Bayesian embedding distributions for free-text
clinical notes and the associated word frequency. We find that rarer words are associated with higher
model uncertainty, with some level of variance at a given frequency.
Table 4: Top and bottom 10 words in free-text clinical notes based on their associated Bayesian
embeddings distribution’s entropy, along with their frequency in the training dataset.
LOWEST ENTROPY HIGHEST ENTROPY
WORD ENTROPY FREQUENCY WORD ENTROPY FREQUENCY
THE -82.5445 41803 24PM -16.0790 336
AND -80.6055 42812 LABWORK -16.0750 272
OF -80.2735 43191 COLONIAL -16.0690 198
NO -79.8994 43420 ZOYSN -16.0601 269
TRACING -78.5988 32181 HT -16.0523 515
IS -78.5553 42560 TXCF -15.9982 112
TO -77.6408 42365 ARRANGEMENTS -15.9795 407
FOR -76.8005 42972 PARVUS -15.9773 132
WITH -75.3513 42819 NAS -15.9164 251
IN -72.8006 42144 ANESTHESIOLOGIST -15.8796 220
Table 4 lists the top and bottom 10 words, along with their frequency in the training dataset. We find
that common words, both subjectively and based on prevalence counts, have low entropy and thus
limited model uncertainty, while rarer words have higher entropy levels, which corresponds to higher
model uncertainty. We additionally measure the correlation between entropy and word frequency
as visualized in Figure 6. We find further confirmation that rarer words are associated with higher
model uncertainty, although there is a level of variance at a given frequency.
5 Discussion
In this work, we demonstrated the need for capturing model uncertainty in medicine and examined
methods to do so. Our experiments showed multiple findings. For example, an ensemble of
deterministic RNNs captures individualized uncertainty conditioned on each patient, while the models
each maintained nearly equivalent clinically-relevant dataset-level metrics. As another example, we
found that models need only be uncertain around the embeddings for competitive performance, with
the benefit of also enabling the ability to determine the the level of model uncertainty associated with
individual feature values. Furthermore, using model uncertainty methods, we examined patterns in
uncertainty across patient subgroups, showing that models can exhibit higher levels of uncertainty for
certain groups.
Future work includes designing more specific decision cost functions based on both quantified
medical ethics [2] and monetary axes, as well as exploring methods to reduce model uncertainty at
both training and prediction time.
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A CCS Multiclass Task
Table 5: Metric performance and calibration statistics for the Clinical Classifications Software task
across M = 50 models in the deterministic RNN ensemble. The models are nearly identical in terms
of dataset-level performance.
METRIC MEAN STANDARD DEVIATION
VAL. TOP-5 RECALL 0.7126 0.0071
VAL. TOP-5 PRECISION 0.1425 0.0014
VAL. TOP-5 F1 0.2375 0.0024
VAL. LOG-LIKELIHOOD -5.1040 0.0075
VAL. ECE 0.0446 0.0072
VAL. ACE 4.2189E-3 7.3111E-8
TEST TOP-5 RECALL 0.7090 0.0088
TEST TOP-5 PRECISION 0.1418 0.0018
TEST TOP-5 F1 0.2363 0.0029
TEST LOG-LIKELIHOOD -5.1081 0.0083
TEST ECE 0.0499 0.0082
TEST ACE 4.2191E-3 7.6136E-8
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Figure 7: Left two: A set of distributions for the maximum predicted probability from our determin-
istic ensemble for two patients in the validation dataset on the mortality task. Note the difference
in x-axis scales. Right two: The corresponding distributions of classes associated with the max
probabilities. Similar to the mortality task, for some patients, such as the one on the left, the ensemble
is relatively certain about the predicted class (completely certain in this case), while for other patients,
such as the one on the right, there is a larger amount of model uncertainty.
In addition to the binary mortality task, we also look at the multiclass Clinical Classifications Software
single-level task on the Medical Information Mart for Intensive Care (MIMIC-III) dataset. The CCS
single-level system categorizes ICD-9-cm codes into 285 distinct categories. For this task, we use the
same deterministic ensemble setup as for the mortality task, but with 50 models. Table 5 displays
the metric performance and calibration statistics for the ensemble on both the validation and test
datsets. We find that, similar to the binary mortality task, the models are nearly equivalent in terms of
performance. Figure 7 examines the distribution of maximum predicted probabilities over the CCS
classes, along with the distribution of predicted classes associated with the maximum probabilities.
Similar to the binary mortality task, this demonstrates the presence of model uncertainty in the
multiclass clinical setting.
B Additional Training Details
Our RNN model uses the same embedding logic as used in [25] to embed sequential and contextual
features. Sequential embeddings are bagged into 1-day blocks, and fed into one or more LSTM
layers. The final time-step output of the LSTM layers is concatenated with the contextual embeddings
and fed into a hidden dense layer, and the output of that layer is then fed into an output dense layer
yielding a single probability value. A ReLU non-linearity is used between the hidden and output
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Table 6: Hyperparameters and their associated search sets or ranges.
HYPERPARAMETER RANGE/SET
BATCH SIZE {32, 64, 128, 256, 512}
LEARNING RATE [0.00001, 0.1]
KL OR REGULARIZATION ANNEALING STEPS [1, 1E6]
PRIOR STANDARD DEVIATION (BAYESIAN ONLY) [0.135, 1.0]
DENSE EMBEDDING DIMENSION {16, 32, 64, 100, 128, 256, 512}
EMBEDDING DIMENSION MULTIPLIER [0.5, 1.5]
RNN DIMENSION {16, 32, 64, 128, 256, 512, 1024}
NUMBER OF RNN LAYERS {1, 2, 3}
HIDDEN AFFINE LAYER DIMENSION {0, 16, 32, 64, 128, 256, 512}
BIAS UNCERTAINTY (BAYESIAN ONLY) {TRUE, FALSE}
Table 7: Model-specific hyperparameter values.
MODEL BATCH
SIZE
LEARN.
RATE
ANNEAL.
STEPS
PRIOR
STD.
DEV.
DENSE
EMBED.
DIM.
EMBED.
DIM.
MULT.
RNN
DIM.
NUM.
RNN
LAYERS
HIDDEN
LAYER
DIM.
BIAS
UNCERT.
DETERMINISTIC
ENSEMBLE 256 3.035E-4 1 – 32 0.858 1024 1 512 –
BAYESIAN
EMBEDDINGS 256 1.238E-3 9.722E+5 0.292 32 0.858 1024 1 512 FALSE
BAYESIAN
OUTPUT 256 1.647E-4 8.782E+5 0.149 32 0.858 1024 1 512 FALSE
BAYESIAN
HIDDEN+OUTPUT 256 2.710E-4 9.912E+5 0.149 32 0.858 1024 1 512 FALSE
BAYESIAN
RNN+HIDDEN
+OUTPUT
512 1.488E-3 6.342E+5 0.252 32 1.291 16 1 0 TRUE
FULLY
BAYESIAN 128 1.265E-3 9.983E+5 0.162 256 1.061 16 1 0 TRUE
dense layers, and default initializers in tf.keras.layers.* are used for all layers. More details on the
training setup can be found in the code3.
In terms of hyperparameter optimization, we searched over the hyperparameters listed in Table 6 for
the original deterministic RNN (all others in the ensemble differ only by the random seed) and each
of the Bayesian models. Table 7 lists the final hyperparameters associated with each of the models
presented in the paper.
Models were implemented using TensorFlow 1.13 [26], and trained on machines equipped with
Nvidia’s P100 using the Adam optimizer [27]. MIMIC-III data were split into train, validation, and
test set in 8:1:1 ratio.
C Additional Metrics and Statistics
In Figure 8, we examine the correlation between held-out log-likelihood and AUC-PR values for
models in the deterministic RNN ensemble on the mortality task.
In Figure 9, we plot the differences between the maximum and minimum predicted probability values
for each patient’s predictive uncertainty distribution. We find that there is wide variability in predicted
probabilities for some patients, and that negative patients have less variability on average.
In Table 8, we measure the calibration of marginalized predictions of our deterministic RNN ensemble
and the Bayesian RNNs.
In Figure 10, we plot the precision-recall (PR) curves of all M models in our deterministic RNN
ensemble across the full dataset along with error bars. We find that the PR curves are nearly identical
for all models, and thus it again seems highly likely that any one of the models could have been
selected if we were focused on our recall-based decision cost function.
3Code will be open-sourced.
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Figure 8: Validation AUC-PR versus held-out log-likelihood values for the deterministic RNN
ensemble on the mortality task. We find that there is no apparent correlation between the two metrics,
likely due to the limited differences between the models.
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Figure 9: A histogram of differences between the maximum and minimum predicted probability
values for each patient’s predictive uncertainty distribution. This shows that there is wide variability
in predicted probabilities for some patients, and that negative patients have less variability on average.
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Table 8: Calibration error for marginalized predictions on the mortality task for an average over
M = 200 models in the deterministic RNN ensemble, and M = 200 samples from each of
the Bayesian RNN models. We find that marginalization slightly increases the calibration of the
deterministic ensemble, and that the Bayesian models are comparably well-calibrated.
MODEL VAL.ECE
VAL.
ACE
TEST
ECE
TEST
ACE
DETERMINISTIC ENSEMBLE 0.0157 0.0191 0.0157 0.0191
BAYESIAN EMBEDDINGS 0.0167 0.0194 0.0163 0.0221
BAYESIAN OUTPUT 0.0263 0.0217 0.0241 0.0279
BAYESIAN HIDDEN+OUTPUT 0.0194 0.0212 0.0173 0.0240
BAYESIAN RNN+HIDDEN+OUTPUT 0.0240 0.0228 0.0182 0.0247
FULLY BAYESIAN 0.0226 0.0192 0.0178 0.0197
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Figure 10: Precision-recall curves for all M = 200 models in the deterministic ensemble. All of the
curves are nearly identical, which is in line with the AUC-PR results.
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